EcoDrugPlus

Anti-Apoptotic Protein Nr13-Like

Ensembl ID : ENSPKIG00000017890
Gene Symbol: LOC111846716
3 Cross references
70 Possible Orthologues:

Apelin Receptor B-Like

Ensembl ID : ENSPKIG00000013312
Gene Symbol: LOC111846763
3 Cross references
171 Possible Orthologues:

Apoptosis Regulator Bcl-2-Like

Ensembl ID : ENSPKIG00000017475
Gene Symbol: LOC111851660
3 Cross references
168 Possible Orthologues:

Apurinic/apyrimidinic Endodeoxyribonuclease 1

Ensembl ID : ENSPKIG00000003504
Gene Symbol: APEX1
3 Cross references
212 Possible Orthologues:

Arachidonate 5-Lipoxygenase Activating Protein

Ensembl ID : ENSPKIG00000015996
Gene Symbol: ALOX5AP
3 Cross references
200 Possible Orthologues:

Arachidonate 5-Lipoxygenase-Like

Ensembl ID : ENSPKIG00000008748
Gene Symbol: LOC111837191
2 Cross references
62 Possible Orthologues:

Arachidonate 5-Lipoxygenase-Like

Ensembl ID : ENSPKIG00000000138
Gene Symbol: LOC111846328
3 Cross references
200 Possible Orthologues:

Arginine Vasopressin Receptor 1ab

Ensembl ID : ENSPKIG00000021118
Gene Symbol: AVPR1AB
1 Cross references
203 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSPKIG00000024364
Gene Symbol: AVPR2
3 Cross references
189 Possible Orthologues:

Aryl Hydrocarbon Receptor-Like

Ensembl ID : ENSPKIG00000008425
Gene Symbol: LOC111839067
3 Cross references
154 Possible Orthologues:

Atrial Natriuretic Peptide Receptor 3-Like

Ensembl ID : ENSPKIG00000014258
Gene Symbol: LOC111856573
3 Cross references
210 Possible Orthologues:

Atrial Natriuretic Peptide Receptor 3-Like

Ensembl ID : ENSPKIG00000016941
Gene Symbol: LOC111849810
3 Cross references
210 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).